Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Apple
AAPL
|
+$273M |
| 3 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$254M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$250M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$406M |
| 2 |
Automatic Data Processing
ADP
|
+$357M |
| 3 |
AABA
Altaba Inc
AABA
|
+$313M |
| 4 |
Meta Platforms (Facebook)
META
|
+$278M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$263M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.08% |
| 2 | Technology | 5.04% |
| 3 | Consumer Discretionary | 3.4% |
| 4 | Energy | 3.22% |
| 5 | Healthcare | 3.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
First Hawaiian
FHB
$3.41B
| $3.67M | ﹤0.01% |
126,515
+114,990
| +998% | +$3.32M |
|
2102
Neurocrine Biosciences
NBIX
$18.2B
| $3.67M | ﹤0.01% |
37,323
+17,325
| +87% | +$1.55M |
|
2103
PUT
Molson Coors Class B
TAP
$8.02B
| $3.67M | ﹤0.01% |
53,900
-5,900
| -10% | -$393K |
|
2104
CALL
Sony
SONY
$137B
| $3.67M | ﹤0.01% |
357,500
-25,000
| -7% | -$243K |
|
2105
PUT
Eagle Materials
EXP
$6.49B
| $3.66M | ﹤0.01% |
34,900
+30,200
| +643% | +$3.18M |
|
2106
PUT
Abercrombie & Fitch
ANF
$4.55B
| $3.66M | ﹤0.01% |
149,600
-26,100
| -15% | -$683K |
|
2107
Invesco CurrencyShares Euro Currency Trust
FXE
$344M
| $3.66M | ﹤0.01% |
32,646
-74,581
| -70% | -$8.54M |
|
2108
Cheniere Energy
CQP
$30.5B
| $3.65M | ﹤0.01% |
101,582
-100,281
| -50% | -$3.3M |
|
2109
Sociedad Química y Minera de Chile
SQM
$19.3B
| $3.65M | ﹤0.01% |
75,920
-24,963
| -25% | -$1.31M |
|
2110
CALL
Baxter International
BAX
$12.8B
| $3.64M | ﹤0.01% |
49,300
-21,000
| -30% | -$1.48M |
|
2111
CALL
Plains All American Pipeline
PAA
$17.6B
| $3.64M | ﹤0.01% |
153,800
+22,800
| +17% | +$549K |
|
2112
AnaptysBio
ANAB
$1.54B
| $3.63M | ﹤0.01% |
51,123
-37,382
| -42% | -$3.14M |
|
2113
Moody's
MCO
$83.7B
| $3.63M | ﹤0.01% |
21,276
-2,519
| -11% | -$426K |
|
2114
Charles River Laboratories
CRL
$11.3B
| $3.62M | ﹤0.01% |
32,211
+971
| +3% | +$105K |
|
2115
ProShares Equities for Rising Rates ETF
EQRR
$32.3M
| $3.61M | ﹤0.01% |
75,000
| – | – |
|
|
SLCA
2116
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $3.61M | ﹤0.01% |
140,378
+21,254
| +18% | +$623K |
|
|
BPMP
2117
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $3.6M | ﹤0.01% |
171,586
+46,272
| +37% | +$923K |
|
|
CY
2118
PUT
DELISTED
Cypress Semiconductor
CY
| $3.6M | ﹤0.01% |
231,200
+173,000
| +297% | +$2.85M |
|
2119
Fastenal
FAST
$54.8B
| $3.6M | ﹤0.01% |
299,296
-134,296
| -31% | -$1.74M |
|
|
GRFS
2120
Grifois
GRFS
$5.55B
| $3.59M | ﹤0.01% |
167,084
+7,519
| +5% | +$164K |
|
|
WUBA
2121
PUT
DELISTED
58.com Inc
WUBA
| $3.59M | ﹤0.01% |
51,800
+12,700
| +32% | +$1.04M |
|
2122
iShares US Healthcare ETF
IYH
$3.44B
| $3.59M | ﹤0.01% |
100,625
-335
| -0.3% | -$11.8K |
|
|
HOLX
2123
CALL
DELISTED
Hologic
HOLX
| $3.58M | ﹤0.01% |
90,200
+32,300
| +56% | +$1.24M |
|
2124
PUT
Teck Resources
TECK
$28.2B
| $3.58M | ﹤0.01% |
140,600
-20,900
| -13% | -$560K |
|
2125
Monster Beverage
MNST
$95.1B
| $3.58M | ﹤0.01% |
124,834
-950,928
| -88% | -$25.7M |
|
Similar funds
Citigroup's Q2 2018 Portfolio in Review
As of Q2 2018, Citigroup held 7,964 positions worth $109B, down 10% from $121B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup withdrew a net $16.6B in Q2 2018, closing 306 positions and reducing 3,274 holdings. Its most notable exit was Monsanto Co, an estimated $159M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5.1% of assets, up from 4.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Global X Artificial Intelligence & Technology ETF worth $40.8M.
- Citigroup's largest Q2 2018 buy was Global X Artificial Intelligence & Technology ETF: 2,719,000 shares worth $40.8M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.04B increase.
- Citigroup's biggest Q2 2018 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $406M.
- Citigroup fully exited Monsanto Co in Q2 2018, selling an estimated $159M.
- Citigroup's ten largest holdings make up 24% of its $109B portfolio in Q2 2018.
- Citigroup opened 380 new positions and closed 306 in Q2 2018.
- Citigroup's portfolio value fell 10% quarter-over-quarter to $109B.
Based on Citigroup's 13F filing for Q2 2018, filed 10 Aug 2018.